This topic contains a solution. Click here to go to the answer

Author Question: A nurse has just initiated a patient's first dose of doxorubicin (Adriamycin). Which assessment ... (Read 56 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
A nurse has just initiated a patient's first dose of doxorubicin (Adriamycin). Which assessment finding would cause the nurse to stop the infusion and seek immediate collaboration with the oncologist?
 
  1. The patient's cardiac monitor reveals sinus bradycardia.
  2. The patient reports being nauseated.
  3. The patient mentions drinking green tea for breakfast.
  4. The patient becomes dyspneic.
  5. The patient becomes pale.

Question 2

The nurse is reviewing some medication administration orders for her clients. Which drug administration abbreviations are matched correctly with their definitions? (Select all that apply.)
 
  1. hshour of sleep/bedtime
  2. acafter meals; after eating
  3. prnwhen needed/necessary
  4. qidthree times per day
  5. pcbefore meals



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

C.mcnichol98

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

1,4
Rationale 1: Bradycardia may indicate cardiac toxicity, which is the major dose-limiting effect.
Rationale 2: Nausea is expected and will be treated with an antiemetic.
Rationale 3: Green tea may enhance the antitumor effect. The nurse should discuss this statement with the oncologist, but it is not necessary to immediately stop the infusion.
Rationale 4: Dyspnea may indicate heart failure.
Rationale 5: The patient may be pale for any number of reasons. It is not necessary to discontinue the infusion.

Global Rationale: Bradycardia may indicate cardiac toxicity, which is the major dose-limiting effect. Dyspnea may indicate heart failure. Nausea is expected and will be treated with an antiemetic. Green tea may enhance the antitumor effect. The nurse should discuss this statement with the oncologist, but it is not necessary to immediately stop the infusion. The patient may be pale for any number of reasons. It is not necessary to discontinue the infusion.

Answer to Question 2

1, 3

Rationale 1:hshour of sleep/bedtime is correctly matched.
Rationale 2:acafter meals; after eating is incorrect because ac means before meals.
Rationale 3:prnwhen needed/necessary is correctly matched.
Rationale4:qidthree times per day is incorrect because qid stands for four times per day.
Rationale 5:pcbefore meals is incorrect because pc means after meals.

Global Rationale: hshour of sleep/bedtime is correctly matched. prnwhen needed/necessary is correctly matched. acafter meals; after eating is incorrect because ac means before meals. qidthree times per day is incorrect because qid stands for four times per day. pcbefore meal is incorrect because pc means after meals.




go.lag

  • Member
  • Posts: 667
Reply 2 on: Jul 23, 2018
Excellent


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library